Barbara H. Johnson

1.9k total citations
61 papers, 1.2k citations indexed

About

Barbara H. Johnson is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Barbara H. Johnson has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Barbara H. Johnson's work include Multiple Sclerosis Research Studies (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Barbara H. Johnson is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Barbara H. Johnson collaborates with scholars based in United States, United Kingdom and Switzerland. Barbara H. Johnson's co-authors include Machaon Bonafede, Jay Lin, Steven Deitelzweig, Crystal Watson, Liisa Palmer, Camilo J. Acosta, Gregory Lenhart, Xue Song, Justin Gatwood and Jeff Bridge and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Barbara H. Johnson

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara H. Johnson United States 19 240 232 217 213 170 61 1.2k
K D MacRae United Kingdom 22 240 1.0× 258 1.1× 97 0.4× 208 1.0× 68 0.4× 66 2.0k
Teresa A. Simon United States 24 454 1.9× 121 0.5× 1.1k 5.2× 404 1.9× 443 2.6× 68 2.5k
F. Guillemin France 18 76 0.3× 50 0.2× 520 2.4× 75 0.4× 115 0.7× 50 1.2k
Anwar H. Nassar Lebanon 28 303 1.3× 31 0.1× 86 0.4× 164 0.8× 71 0.4× 155 3.0k
Corianne A.J.M. de Borgie Netherlands 16 376 1.6× 42 0.2× 95 0.4× 39 0.2× 127 0.7× 32 1.5k
Dahlia Weitzman Israel 20 270 1.1× 27 0.1× 185 0.9× 139 0.7× 112 0.7× 37 1.2k
Seán Kennedy Australia 22 245 1.0× 31 0.1× 51 0.2× 83 0.4× 49 0.3× 102 1.7k
Kamal Kant Sahu United States 22 169 0.7× 25 0.1× 48 0.2× 88 0.4× 75 0.4× 178 1.7k
Thomas V. Jones United States 16 408 1.7× 39 0.2× 445 2.1× 33 0.2× 177 1.0× 49 1.4k
Sheila Jacobson Canada 18 218 0.9× 56 0.2× 106 0.5× 71 0.3× 68 0.4× 31 1.8k

Countries citing papers authored by Barbara H. Johnson

Since Specialization
Citations

This map shows the geographic impact of Barbara H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara H. Johnson more than expected).

Fields of papers citing papers by Barbara H. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara H. Johnson. The network helps show where Barbara H. Johnson may publish in the future.

Co-authorship network of co-authors of Barbara H. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara H. Johnson. A scholar is included among the top collaborators of Barbara H. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara H. Johnson. Barbara H. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Barbara H., et al.. (2023). Clinical and Economic Burden Associated with Prolonged Air Leaks Among Patients Undergoing Thoracic Resection: A Retrospective Database Analysis. ClinicoEconomics and Outcomes Research. Volume 15. 269–280. 1 indexed citations
2.
Fan, Xiaozhou, et al.. (2021). Monthly trend in mortality and length of stay among coronavirus disease 2019 (COVID-19) patients: Analysis of a nationwide multihospital US database. Infection Control and Hospital Epidemiology. 42(9). 1132–1135. 1 indexed citations
3.
Fan, Xiaozhou, et al.. (2021). Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020–July 2020. International Journal of General Medicine. Volume 14. 267–271. 4 indexed citations
4.
5.
Johnson, Barbara H., Stephen S. Johnston, Mohit Bhandari, et al.. (2020). <p>Comparative Effectiveness Assessment of Two Powered Surgical Stapling Platforms in Laparoscopic Sleeve Gastrectomy: A Retrospective Matched Study</p>. Medical Devices Evidence and Research. Volume 13. 195–204. 8 indexed citations
6.
Bowen, James D., Rina Mehta, Corey Pelletier, et al.. (2020). Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy. Advances in Therapy. 37(7). 3163–3177. 12 indexed citations
7.
Boytsov, Natalie, Xiang Zhang, Kristin Evans, & Barbara H. Johnson. (2019). Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis. PharmacoEconomics - Open. 4(1). 105–117. 16 indexed citations
8.
Fishman, Jesse, Melinda S. Martin, David M. Labiner, Carolyn R. Lew, & Barbara H. Johnson. (2019). Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States. Epilepsy & Behavior. 99. 106331–106331. 7 indexed citations
9.
Johnson, Barbara H., Machaon Bonafede, & Crystal Watson. (2015). Direct Medical Burden And Readmission Rates Among Non-Elderly Patients With Acute Ischemic Stroke In The United States. Value in Health. 18(3). A139–A139.
10.
Carter, Gebra Cuyún, Pamela Landsman‐Blumberg, Barbara H. Johnson, et al.. (2015). KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis. Journal of Experimental & Clinical Cancer Research. 34(1). 29–29. 13 indexed citations
11.
Johnson, Barbara H., Machaon Bonafede, & Crystal Watson. (2015). Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients. CNS Drugs. 29(6). 503–510. 13 indexed citations
12.
Capkun, Gorana, Raquel Lahoz, E. Verdun, et al.. (2015). Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Current Medical Research and Opinion. 31(5). 1029–1039. 25 indexed citations
13.
Bonafede, Machaon, Barbara H. Johnson, Nicole Princic, Neel Shah, & David J. Harrison. (2014). Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population. Value in Health. 17(3). A46–A47.
14.
Bonafede, Machaon, Barbara H. Johnson, Nicole Princic, Neel Shah, & David J. Harrison. (2014). Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. Journal of Medical Economics. 18(5). 376–389. 15 indexed citations
15.
Bonafede, Machaon, Barbara H. Johnson, Madé Wenten, & Crystal Watson. (2013). Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States. Clinical Therapeutics. 35(10). 1501–1512. 26 indexed citations
16.
Bonafede, Machaon, Barbara H. Johnson, & Crystal Watson. (2013). Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US. ClinicoEconomics and Outcomes Research. 6. 11–11. 13 indexed citations
17.
Bonafede, Machaon, Kathleen M. Fox, Barbara H. Johnson, Crystal Watson, & Shravanthi R. Gandra. (2012). Factors Associated With the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study. Clinical Therapeutics. 34(2). 457–467. 25 indexed citations
18.
Smoyer‐Tomic, Karen E., Kimberly Siu, David Walker, et al.. (2012). Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation. American Journal of Cardiovascular Drugs. 12(6). 403–413. 18 indexed citations
19.
Deitelzweig, Steven, et al.. (2010). Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections. American Journal of Hematology. 86(2). 217–220. 182 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K D MacRae Breakdown of academic impact, for papers by Teresa A. Simon Breakdown of academic impact, for papers by F. Guillemin Breakdown of academic impact, for papers by Anwar H. Nassar Breakdown of academic impact, for papers by Corianne A.J.M. de Borgie Breakdown of academic impact, for papers by Dahlia Weitzman Breakdown of academic impact, for papers by Seán Kennedy Breakdown of academic impact, for papers by Kamal Kant Sahu Breakdown of academic impact, for papers by Thomas V. Jones Breakdown of academic impact, for papers by Sheila Jacobson
Rankless by CCL
2026